Tracking Medicare news, policy, and coverage changes.
A fragmented system built on isolated metrics like BMI and A1C fails to capture the full picture of metabolic health and limits our ability to manage it effectively. The post Are We Measuring Metabolic Health All Wrong? appeared first on MedCity News .
Read full article →By adopting interpretation-driven, clinically intelligent technologies, revenue cycle teams can ensure that every nuance of care is accurately represented. This safeguards revenue integrity while maintaining the highest standards of compliance. The post Scaling AI in Health Systems: From Innovation to Sustainable Implementation appeared first on MedCity News .
Read full article →Every month a legitimate workflow improvement sits in queue, the organization pays for the problem twice: once in the inefficiency the change was supposed to fix, and again in the workaround everyone built to get through the week. The backlog doesn’t show up as a line item. It shows up everywhere else. The post The Most Expensive Queue in Healthcare Isn’t Prior Auth — It’s the IT Backlog appeared first on MedCity News .
Read full article →The FDA has missed a self-imposed deadline to ban the use of electrical shock devices in people with intellectual disabilities.
Read full article →We've been asking Medicare for weeks about the cost of giving seniors $50 obesity drugs.
Read full article →Detailed study data for a pancreatic cancer treatment from Revolution Medicines confirmed it increased overall survival, from 13.2 months to 6.7 months
Read full article →“You have to understand a person's belief if you want to address it,” Deva Sharma says on the “First Opinion Podcast” about requests for unvaccinated donor blood.
Read full article →Eli Lilly announces two China deals, Akeso's lung cancer bispecific payoff, and more biotech news from The Readout
Read full article →The Trump administration disregards infectious disease playbook, CEPI offers vaccine funding, and other health news from Morning Rounds
Read full article →The French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55 billion upfront.
Read full article →A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.
Read full article →(MedPage Today) -- Plasma exchange with albumin 5% (Albutein 5%, PE-A5%) added to standard medical treatment (SMT) improved outcomes in patients with acute-on-chronic liver failure (ACLF), according to the randomized phase III APACHE trial. Among...
Read full article →